Genomic Engineering in Medicine: Gene and Cell Therapy
This Technology Explainer explores the rising role of genomic engineering in medicine and its emergent ability to detect, treat, and cure human disease at the genetic root. While genomic engineering encompasses a broad array of approaches, this Explainer narrows its scope to gene and cell therapy, distinct yet closely intertwined strategies in clinical practice. Given the highly complementary functions of gene and cell therapy, this discussion examines both their individual and combinatorial capabilities. This Explainer discusses the scientific foundations and clinical impact of gene and cell therapy, then turns to legal and policy considerations associated with their widespread adoption.
Mary K. Bass
Georgetown University Law Center, Allen and Erika Lo Endowed Tech Scholar, J.D. Candidate 2027; Stanford University, B.A. in Public Policy, 2014. This Article benefited greatly from the insights of Kyle M. Loh, Assistant Professor of Developmental Biology at Stanford University School of Medicine. I am grateful to my family, classmates, colleagues, and the editors of the Georgetown Technology Law Review for their thoughtful feedback and support throughout the publication process.